Transoral Robotic Surgery in the Multidisciplinary Care of Patients With Oropharyngeal Squamous Cell Carcinoma: ASCO Guideline

Gastrointestinal Cancer

Systemic Therapy for Stage I-III Anal Squamous Cell Carcinoma: ASCO Guideline

J Clin Oncol

Morris VK, Kennedy EB, Amin MA, Aranha O, Benson AB 3rd, Dorth JA, Horowitz DP, Kennecke HF, Kim S, Kreppel L, Mettu NB, Rajdev L, Riechelmann R, Sio TT, Eng C

doi: 10.1200/JCO-24-02120

Further Publications

Palliative Care for Patients With Cancer: ASCO Guideline Update

J Clin Oncol

Sanders JJ, Temin S, Ghoshal A, Alesi ER, Ali ZV, Chauhan C, Cleary JF, Epstein AS, Firn JI, Jones JA, Litzow MR, Lundquist D, Mardones MA, Nipp RD, Rabow MW, Rosa WE, Zimmermann C, Ferrell BR

doi: 10.1200/JCO.24.00542

Head and Neck Cancer

A systematic review of antibody-drug conjugates and bispecific antibodies in head and neck squamous cell carcinoma and nasopharyngeal carcinoma: Charting the course of future therapies

Cancer Treat Rev

Jiménez-Labaig P, Rullan A, Hernando-Calvo A, Llop S, Bhide S, O'Leary B, Braña I, Harrington KJ

doi: 10.1016/j.ctrv.2024.102772

Genitourinary Cancer

The incidence of immune-related adverse events (irAEs) and their association with clinical outcomes in advanced renal cell carcinoma and urothelial carcinoma patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis

Cancer Treat Rev

Zhang Y, Chen J, Liu H, Dai J, Zhao J, Zhu S, Zhang X, Liang J, Hu X, Zhao J, Liu Z, Shen P, Sun G, Zeng H

doi: 10.1016/j.ctrv.2024.102787

Further Publications

Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline

J Clin Oncol

Tung N, Ricker C, Messersmith H, Balmaña J, Domchek S, Stoffel EM, Almhanna K, Arun B, Chavarri-Guerra Y, Cohen SA, Cragun D, Crew KD, Hall MJ, Idos G, Lopez G, Pal T, Pirzadeh-Miller S, Pritchard C, Rana HQ, Swami U, Vidal GA

doi: 10.1200/JCO.24.00662

Head and Neck Cancer

Intratumoral therapies in head and neck squamous cell carcinoma: A systematic review and future perspectives

Cancer Treat Rev

Jiménez-Labaig P, Rullan A, Braña I, Hernando-Calvo A, Moreno V, Doger B, Bitar G, Ap Dafydd D, Melcher A, Harrington KJ

doi: 10.1016/j.ctrv.2024.102746

Skin Cancer

Human papillomavirus-related squamous cell carcinomas after blood or marrow transplantation-a BMTSS report

J Natl Cancer Inst

Holmqvist AS, Meng Q, Landier W, Hageman L, Francisco LF, Ross ES, Balas N, Bosworth A, Te HS, Bhatia R, Wong FL, Weisdorf D, Armenian SH, Bhatia S

doi: 10.1093/jnci/djaf021

Head and Neck Cancer

Response to induction chemotherapy as a prognostic indicator in locally advanced head and neck squamous cell carcinoma

J Cancer Res Clin Oncol

Huwyler F, Giger R, Bill R, Rauch D, Haefliger S

doi: 10.1007/s00432-024-06044-2

Head and Neck Cancer

Pembrolizumab and cabozantinib in recurrent and/or metastatic head and neck squamous cell carcinoma (RMHNSCC): long-term survival update with a biomarker analysis

Clin Cancer Res

Saba NF, Chaudhary R, Kirtane K, Marra A, Ekpenyong A, McCook-Veal A, Schmitt NC, Gross JH, Patel MR, Remick J, Bates JE, McDonald MW, Rudra SF, Stokes WA, Biernacki M, Song X, Slebos RJC, Liu Y, Steuer CE, Shin DM, Teng Y, Chung CH

doi: 10.1158/1078-0432.CCR-24-1202

Related content

Systemic Therapy for Stage I-III Anal Squamous Cell Carcinoma: ASCO Guideline

Palliative Care for Patients With Cancer: ASCO Guideline Update

A systematic review of antibody-drug conjugates and bispecific antibodies in head and neck squamous cell carcinoma and nasopharyngeal carcinoma: Charting the course of future therapies

The incidence of immune-related adverse events (irAEs) and their association with clinical outcomes in advanced renal cell carcinoma and urothelial carcinoma patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis

Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline

Intratumoral therapies in head and neck squamous cell carcinoma: A systematic review and future perspectives

Human papillomavirus-related squamous cell carcinomas after blood or marrow transplantation-a BMTSS report

Response to induction chemotherapy as a prognostic indicator in locally advanced head and neck squamous cell carcinoma

Pembrolizumab and cabozantinib in recurrent and/or metastatic head and neck squamous cell carcinoma (RMHNSCC): long-term survival update with a biomarker analysis